{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:22:46Z","timestamp":1787761366563,"version":"build-2784847793"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Strategic Priority Research Program of Chinese Academy of Sciences","award":["XDB38010100"],"award-info":[{"award-number":["XDB38010100"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82100857"],"award-info":[{"award-number":["82100857"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82300904"],"award-info":[{"award-number":["82300904"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Anhui Provincial Health Research Project","award":["AHWJ2024Aa20543"],"award-info":[{"award-number":["AHWJ2024Aa20543"]}]},{"name":"Project of State Key Clinical Department","award":["Z2023058"],"award-info":[{"award-number":["Z2023058"]}]},{"name":"Chinese Cardiovascular Association-ASCVD Fund","award":["2023-CCAASCVD-018"],"award-info":[{"award-number":["2023-CCAASCVD-018"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s12072-026-11103-6","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T11:41:30Z","timestamp":1779795690000},"page":"1047-1057","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical clustering identifies MASLD subtypes with distinct longitudinal cardiovascular risks and lipidomic profiles"],"prefix":"10.1007","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8856-0245","authenticated-orcid":false,"given":"Zhixin","family":"Tu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongqiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingting","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sihui","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,26]]},"reference":[{"issue":"3","key":"11103_CR1","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.jhep.2023.04.036","volume":"79","author":"VW-S Wong","year":"2023","unstructured":"Wong VW-S, Ekstedt M, Wong GL-H, Hagstr\u00f6m H. Changing epidemiology, global trends and implications for outcomes of NAFLD. J Hepatol. 2023;79(3):842\u2013852. https:\/\/doi.org\/10.1016\/j.jhep.2023.04.036","journal-title":"J Hepatol"},{"issue":"4","key":"11103_CR2","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","volume":"77","author":"ZM Younossi","year":"2023","unstructured":"Younossi ZM, Golabi P, Paik JM, Henry A, Van Dongen C, Henry L. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology. 2023;77(4):1335\u20131347. https:\/\/doi.org\/10.1097\/HEP.0000000000000004","journal-title":"Hepatology"},{"issue":"6","key":"11103_CR3","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","volume":"78","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Lazarus JV, Ratziu V, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology. 2023;78(6):1966\u20131986. https:\/\/doi.org\/10.1097\/HEP.0000000000000520","journal-title":"Hepatology"},{"issue":"1","key":"11103_CR4","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","volume":"73","author":"M Eslam","year":"2020","unstructured":"Eslam M, Newsome PN, Sarin SK, et al. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement. J Hepatol. 2020;73(1):202\u2013209. https:\/\/doi.org\/10.1016\/j.jhep.2020.03.039","journal-title":"J Hepatol"},{"issue":"4","key":"11103_CR5","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1136\/gutjnl-2023-330595","volume":"73","author":"G Targher","year":"2024","unstructured":"Targher G, Byrne CD, Tilg H. MASLD: a systemic metabolic disorder with cardiovascular and malignant complications. Gut. 2024;73(4):691\u2013702. https:\/\/doi.org\/10.1136\/gutjnl-2023-330595","journal-title":"Gut"},{"issue":"2","key":"11103_CR6","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/S2213-8587(24)00318-8","volume":"13","author":"N Stefan","year":"2025","unstructured":"Stefan N, Yki-J\u00e4rvinen H, Neuschwander-Tetri BA. Metabolic dysfunction-associated steatotic liver disease: heterogeneous pathomechanisms and effectiveness of metabolism-based treatment. Lancet Diabetes Endocrinol. 2025;13(2):134\u2013148. https:\/\/doi.org\/10.1016\/S2213-8587(24)00318-8","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"772","key":"11103_CR7","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adh9940","volume":"16","author":"J Ding","year":"2024","unstructured":"Ding J, Liu H, Zhang X, et al. Integrative multiomic analysis identifies distinct molecular subtypes of NAFLD in a Chinese population. Sci Transl Med. 2024;16(772): eadh9940. https:\/\/doi.org\/10.1126\/scitranslmed.adh9940","journal-title":"Sci Transl Med"},{"key":"11103_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics15030342","author":"G Ryu","year":"2025","unstructured":"Ryu G, Yoon EL, Kim W, Jun DW. Molecular clustering of metabolic dysfunction-associated steatotic liver disease based on transcriptome analysis. Diagnostics (Basel). 2025. https:\/\/doi.org\/10.3390\/diagnostics15030342","journal-title":"Diagnostics (Basel)"},{"issue":"12","key":"11103_CR9","doi-asserted-by":"publisher","first-page":"3624","DOI":"10.1038\/s41591-024-03283-1","volume":"30","author":"V Raverdy","year":"2024","unstructured":"Raverdy V, Tavaglione F, Chatelain E, et al. Data-driven cluster analysis identifies distinct types of metabolic dysfunction-associated steatotic liver disease. Nat Med. 2024;30(12):3624\u20133633. https:\/\/doi.org\/10.1038\/s41591-024-03283-1","journal-title":"Nat Med"},{"issue":"3","key":"11103_CR10","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.jhep.2024.04.031","volume":"81","author":"EASL-EASD-EASO Clinical Practice Guidelines","year":"2024","unstructured":"EASL-EASD-EASO Clinical Practice Guidelines. On the management of metabolic dysfunction-associated steatotic liver disease (MASLD). J Hepatol. 2024;81(3):492\u2013542. https:\/\/doi.org\/10.1016\/j.jhep.2024.04.031","journal-title":"J Hepatol"},{"issue":"1","key":"11103_CR11","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1186\/s12874-021-01440-5","volume":"21","author":"E Bosco","year":"2021","unstructured":"Bosco E, Hsueh L, McConeghy KW, Gravenstein S, Saade E. Major adverse cardiovascular event definitions used in observational analysis of administrative databases: a systematic review. BMC Med Res Methodol. 2021;21(1):241\u2013241. https:\/\/doi.org\/10.1186\/s12874-021-01440-5","journal-title":"BMC Med Res Methodol"},{"key":"11103_CR12","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s11306-016-1030-9","volume":"12","author":"R Di Guida","year":"2016","unstructured":"Di Guida R, Engel J, Allwood JW, et al. Non-targeted UHPLC-MS metabolomic data processing methods: a comparative investigation of normalisation, missing value imputation, transformation and scaling. Metabolomics. 2016;12:93","journal-title":"Metabolomics"},{"key":"11103_CR13","doi-asserted-by":"publisher","DOI":"10.1093\/gigascience\/gix087","author":"C Zeng","year":"2017","unstructured":"Zeng C, Wen B, Hou G, et al. Lipidomics profiling reveals the role of glycerophospholipid metabolism in psoriasis. Gigascience. 2017. https:\/\/doi.org\/10.1093\/gigascience\/gix087","journal-title":"Gigascience"},{"key":"11103_CR14","unstructured":"Lundberg SM, Lee S-I. A unified approach to interpreting model predictions. Presented at: proceedings of the 31st international conference on neural information processing systems. Long Beach; 2017."},{"issue":"8","key":"11103_CR15","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1016\/j.jacc.2018.11.050","volume":"73","author":"EP Stahl","year":"2019","unstructured":"Stahl EP, Dhindsa DS, Lee SK, Sandesara PB, Chalasani NP, Sperling LS. Nonalcoholic fatty liver disease and the heart: JACC state-of-the-art review. J Am Coll Cardiol. 2019;73(8):948\u2013963. https:\/\/doi.org\/10.1016\/j.jacc.2018.11.050","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"11103_CR16","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.jhep.2016.05.013","volume":"65","author":"G Targher","year":"2016","unstructured":"Targher G, Byrne CD, Lonardo A, Zoppini G, Barbui C. Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: a meta-analysis. J Hepatol. 2016;65(3):589\u2013600. https:\/\/doi.org\/10.1016\/j.jhep.2016.05.013","journal-title":"J Hepatol"},{"issue":"1","key":"11103_CR17","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1186\/s12876-025-04133-1","volume":"25","author":"MJ Trejo","year":"2025","unstructured":"Trejo MJ, Floyd JS, Massera D, et al. Association of liver related biomarkers with incident cardiovascular disease and all-cause mortality in the Hispanic community health study\/study of Latinos (HCHS\/SOL), a population-based cohort study. BMC Gastroenterol. 2025;25(1):543. https:\/\/doi.org\/10.1186\/s12876-025-04133-1","journal-title":"BMC Gastroenterol"},{"issue":"1","key":"11103_CR18","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2025.2486594","volume":"57","author":"Z Gui","year":"2025","unstructured":"Gui Z, Chen X, Wang D, et al. Inflammatory and metabolic markers mediate the association of hepatic steatosis and fibrosis with 10-year ASCVD risk. Ann Med. 2025;57(1): 2486594. https:\/\/doi.org\/10.1080\/07853890.2025.2486594","journal-title":"Ann Med"},{"issue":"9733","key":"11103_CR19","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1016\/S0140-6736(10)60408-4","volume":"375","author":"VT Samuel","year":"2010","unstructured":"Samuel VT, Petersen KF, Shulman GI. Lipid-induced insulin resistance: unravelling the mechanism. Lancet. 2010;375(9733):2267\u20132277. https:\/\/doi.org\/10.1016\/S0140-6736(10)60408-4","journal-title":"Lancet"},{"issue":"4","key":"11103_CR20","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1002\/hep.21763","volume":"46","author":"P Puri","year":"2007","unstructured":"Puri P, Baillie RA, Wiest MM, et al. A lipidomic analysis of nonalcoholic fatty liver disease. Hepatology. 2007;46(4):1081\u20131090","journal-title":"Hepatology"},{"issue":"28","key":"11103_CR21","doi-asserted-by":"publisher","first-page":"23418","DOI":"10.1074\/jbc.M112.381723","volume":"287","author":"JN van der Veen","year":"2012","unstructured":"van der Veen JN, Lingrell S, Vance DE. The membrane lipid phosphatidylcholine is an unexpected source of triacylglycerol in the liver. J Biol Chem. 2012;287(28):23418\u201323426. https:\/\/doi.org\/10.1074\/jbc.M112.381723","journal-title":"J Biol Chem"},{"key":"11103_CR22","doi-asserted-by":"publisher","DOI":"10.1097\/HC9.0000000000000716","author":"D Guardamino Ojeda","year":"2025","unstructured":"Guardamino Ojeda D, Yalcin Y, Pita-Juarez Y, et al. VLDL lipidomics reveals hepatocellular lipidome changes in metabolic dysfunction-associated steatotic liver disease. Hepatol Commun. 2025. https:\/\/doi.org\/10.1097\/HC9.0000000000000716","journal-title":"Hepatol Commun"},{"issue":"3","key":"11103_CR23","doi-asserted-by":"publisher","first-page":"e320","DOI":"10.1016\/j.jacl.2024.04.001","volume":"18","author":"HE Bays","year":"2024","unstructured":"Bays HE, Kirkpatrick CF, Maki KC, et al. Obesity, dyslipidemia, and cardiovascular disease: a joint expert review from the Obesity Medicine Association and the National Lipid Association 2024. J Clin Lipidol. 2024;18(3):e320\u2013e350. https:\/\/doi.org\/10.1016\/j.jacl.2024.04.001","journal-title":"J Clin Lipidol"},{"issue":"6","key":"11103_CR24","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.2337\/dc17-1318","volume":"41","author":"M Apostolopoulou","year":"2018","unstructured":"Apostolopoulou M, Gordillo R, Koliaki C, et al. Specific hepatic sphingolipids relate to insulin resistance, oxidative stress, and inflammation in Nonalcoholic Steatohepatitis. Diabetes Care. 2018;41(6):1235\u20131243. https:\/\/doi.org\/10.2337\/dc17-1318","journal-title":"Diabetes Care"},{"issue":"3","key":"11103_CR25","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/nrm.2017.107","volume":"19","author":"YA Hannun","year":"2018","unstructured":"Hannun YA, Obeid LM. Sphingolipids and their metabolism in physiology and disease. Nat Rev Mol Cell Biol. 2018;19(3):175\u2013191. https:\/\/doi.org\/10.1038\/nrm.2017.107","journal-title":"Nat Rev Mol Cell Biol"},{"key":"11103_CR26","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvaf093","author":"R Klingenberg","year":"2025","unstructured":"Klingenberg R, Leiherer A, Dobrev D, et al. Ceramides in cardiovascular disease - emerging role as independent risk predictors and novel therapeutic targets. Cardiovasc Res. 2025. https:\/\/doi.org\/10.1093\/cvr\/cvaf093","journal-title":"Cardiovasc Res"},{"issue":"8","key":"11103_CR27","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.2337\/db17-1449","volume":"67","author":"RN Lemaitre","year":"2018","unstructured":"Lemaitre RN, Yu C, Hoofnagle A, et al. Circulating sphingolipids, insulin, HOMA-IR, and HOMA-B: the strong heart family study. Diabetes. 2018;67(8):1663\u20131672. https:\/\/doi.org\/10.2337\/db17-1449","journal-title":"Diabetes"},{"issue":"3","key":"11103_CR28","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1172\/JCI131838","volume":"130","author":"AM Poss","year":"2020","unstructured":"Poss AM, Maschek JA, Cox JE, et al. Machine learning reveals serum sphingolipids as cholesterol-independent biomarkers of coronary artery disease. J Clin Invest. 2020;130(3):1363\u20131376. https:\/\/doi.org\/10.1172\/JCI131838","journal-title":"J Clin Invest"},{"issue":"1","key":"11103_CR29","doi-asserted-by":"publisher","first-page":"e70105","DOI":"10.1111\/cts.70105","volume":"18","author":"AO Basile","year":"2025","unstructured":"Basile AO, Verma A, Tang LA, et al. Rapid identification and phenotyping of nonalcoholic fatty liver disease patients using a machine-based approach in diverse healthcare systems. Clin Transl Sci. 2025;18(1):e70105. https:\/\/doi.org\/10.1111\/cts.70105","journal-title":"Clin Transl Sci"},{"issue":"1","key":"11103_CR30","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1186\/s12967-025-06670-5","volume":"23","author":"C Hong","year":"2025","unstructured":"Hong C, Liang S-X, Li Z-Y, et al. Novel subtypes of metabolic associated steatotic liver disease linked to clinical outcomes: implications for precision medicine. J Transl Med. 2025;23(1):769. https:\/\/doi.org\/10.1186\/s12967-025-06670-5","journal-title":"J Transl Med"},{"key":"11103_CR31","doi-asserted-by":"publisher","DOI":"10.1210\/endrev\/bnaf018","author":"J Dong","year":"2025","unstructured":"Dong J, Dennis KMJH, Venkatakrishnan R, Hodson L, Tomlinson JW. The impact of estrogen deficiency on liver metabolism; implications for hormone replacement therapy. Endocr Rev. 2025. https:\/\/doi.org\/10.1210\/endrev\/bnaf018","journal-title":"Endocr Rev"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-026-11103-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12072-026-11103-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-026-11103-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:40:55Z","timestamp":1787758855000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12072-026-11103-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,26]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["11103"],"URL":"https:\/\/doi.org\/10.1007\/s12072-026-11103-6","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,26]]},"assertion":[{"value":"16 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Zhixin Tu, Yu Ding, Tong Yue, Hongqiang Zhang, Ting Peng, Pingting Yang, Weiwei Qin, Jiangang Wang, Jianping Weng and Sihui Luo have declared no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study has been approved by the Ethics Committee of the First Affiliated Hospital of the University of Science and Technology of China (No. 2021KY034 and No.2023KY383), and all participants provided written informed consent.","order":2,"name":"Ethics","label":"Ethical approval and informed consent","group":{"name":"EthicsHeading","label":"Declarations"}}]}}